Medivir presents MIV-818 data at AACR-NCI-EORTC in BostonRead more
US National Cancer Institute initiates phase I study of treatment of head and neck cancer patients with Medivir’s birinapant and radiation therapyRead more
MEDIVIR AB – INTERIM REPORT JANUARY – JUNE 2019Read more
Quarterly report presentations
Medivir Corporate Governance documention.
Documentation from Medivir's Annual General Meetings.